Sente, Inc. Raises $2.1M in Series B Equity Financing

Liquid error (sections/article-main line 13): invalid url input

Funding to Support Commercial Operations and Additional Line Extensions to Senté’s Portfolio of Differentiated Skincare Products Based on Glycoproteins

SAN DIEGO, May 14, 2013 (GLOBE NEWSWIRE) — Senté, Inc., a privately held cosmeceutical company engaged in the development of differentiated skincare products based on glycoproteins, announced today that it has closed its Series-B financing, raising $2.1 million from a combination of new and existing biotechnology investors. This financing provides Senté with a sizable cash balance to fund continued company growth.

Proceeds from the financing will help Senté, Inc. expand commercial operations, scale development capabilities, and add additional line extensions to its portfolio of differentiated skincare products.

“We are very pleased to see such strong investor interest in our company from experts in the healthcare and aesthetic field,” said Kleanthis G. Xanthopoulos, Ph.D., Senté Co-Founder and Board Member. “Our new investors share our vision of creating unique science based products that will have profound impacts on the skin, and we very much look forward to working with them on this endeavor.”

“It has been our privilege to serve our initial physician clients and their patients,” said Faheem Hasnain, Chairman of the Board of Senté, Inc. “Their stories and early signs of success are the primary motivation for our work and we are happy to have assembled such an outstanding group of investors to support our mission. The financial capabilities and strategic aspects of this round will help us take Senté to the next level.”

About Senté, Inc.

Senté, Inc., a privately held specialty aesthetics company, is a recognized leader in the development of innovative and targeted skincare products utilizing HSA technology, a low molecular weight formulation of heparan sulfate. HSA is essential for skin hydration, rejuvenation and necessary for healthy-looking skin. Senté was founded in 2007 and is based in San Diego, California. Further information may be found at https://sentelabs.com/. Senté products are available through an exclusive network of physicians, medically supervised spas.

SENTÉ Press Contact:

Creative Media Marketing
sente@cmmpr.com
(212) 979-8884